Gyrification abnormalities in presymptomatic <i>c9orf72</i> expansion carriers.
cross_sectional · Level IV
Where this comes from
- Record sourced from PubMed, PMID 31079065.
- Also identified by DOI 10.1136/jnnp-2018-320265 and PMC identifier 6820159.
- Licence recorded as CC BY-NC.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
To investigate in-vivo cortical gyrification patterns measured by the local gyrification index (lGI) in presymptomatic <i>c9orf72</i> expansion carriers compared with healthy controls, and investigate relationships between lGI and cortical thickness, an established morphometric measure of neurodegeneration. We assessed cortical gyrification and thickness patterns in a cohort of 15 presymptomatic <i>c9orf72</i> expansion carriers (age 43.7 ± 10.2 years, 9 females) compared with 67 (age 42.4 ± 12.4 years, 36 females) age and sex matched healthy controls using the dedicated Freesurfer pipeline. Compared with controls, presymptomatic carriers showed significantly lower lGI in left frontal and right parieto-occipital regions. Interestingly, those areas with abnormal gyrification in presymptomatic carriers showed no concomitant cortical thickness abnormality. Overall, for both presymptomatic carriers and healthy controls, gyrification and cortical thickness measures were not correlated, suggesting that gyrification captures a feature distinct from cortical thickness. Presymptomatic <i>c9orf72</i> expansion carriers show regions of abnormally low gyrification as early as their 30s, decades before expected symptom onset. Cortical gyrification represents a novel grey matter metric distinctive from grey matter thickness or volume and detects differences in presymptomatic carriers at an early age.
Medical subject headings
- C9orf72 Protein
- Cerebral Cortex
- Heterozygote